|
ACHL |
Share:
|
A New Path Forward: The Therapeutic Potential of Next Generation BTK Inhibitors in CLL/SLL
Emerging BTK inhibitors are positioned to change the landscape and impact your chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) treatment plans. Are you ready to incorporate these emerging therapies into your treatment plans? Dr. Sameer Parikh discusses these emerging BTK inhibitors for CLL/SLL, how they differ from current approaches, and future opportunities to introduce the...
|
|
Adaptive Learning to Improve Individualized Management of Type 2 Diabetes (T2D)
As a primary care provider, you play a critical role in the management of patients with type 2 diabetes. ACHL AdaptED® offers a unique experience designed to meet the needs of busy clinicians seeking to enhance their expertise in this area. Our adaptive learning platform allows you to tailor your educational experience to match your specific learning goals and knowledge gaps. This activity has ...
|
|
Addressing the Barriers to Medical Treatment for Alcohol Use Disorder (AUD)
Alcohol use disorder (AUD) has a significant burden on patients and their loved ones. AUD is treatable with medication and psychosocial counseling; however, patients with AUD are undertreated particularly in the primary care setting. This case challenge activity will replicate real-world practice and provide evidence-based treatment recommendations for AUD, including pharmacotherapy, along with ...
|
|
Answers to the Questions You May Not be Asking: Treating Ulcerative Colitis Considerate of Patient-Centric Factors
Are you aware of the latest evidence-based strategies in ulcerative colitis (UC)? Looking to expand your ability to incorporate patient-centric factors into selection of therapy for UC? Navigate through this novel, interactive self-directed activity designed to optimize your decision making in selection of therapy for UC. View expert perspectives and insights who can help you apply newer strate...
|
|
Breaking the Cycle: The Role of Microbiota-Based Biotherapies in the Reduction of Recurrent Clostridioides difficile
Drs. Paul Feuerstadt, Sahil Khanna, Teena Chopra and Caterina Oneto convened at annual gastroenterology and infectious disease congresses to discuss clinical scenarios and best practices to manage recurrent Clostridioides difficile (C. difficile) infections; this activity chronicles their discussions. Tune in for updates on risk factors and prevention strategies for recurrent infection, as well ...
|
|
Collaborative Management Strategies for Acute/Urgent Care in Short Bowel Syndrome
Patients with short bowel syndrome (SBS) may present in an acute care setting for many reasons, including diarrhea, dehydration, bowel obstruction, gallstones, and complications related to parenteral nutrition (PN) such as infections. In this Clinical Commentary video with accompanying downloadable infographic, physicians, nurses, NPs, and PAs within the urgent care and emergency department sett...
|
|
Emerging Strategies for Optimizing and Simplifying the Management of Resistant Hypertension
Delve into emerging therapies for resistant hypertension in this symposium highlights video. Hear from a multidisciplinary panel of experts discussing the current state of evaluation, diagnosis, and management of resistant hypertension, along with the challenges faced by clinicians. A patient case study and panel discussion provide practical advice for improving patient outcomes within the evolv...
|
|
Emerging Therapies, Novel Mechanisms, and New Hope in the Treatment of PAH
The treatment landscape of pulmonary arterial hypertension (PAH) is poised to change dramatically in the near future. Designed with your questions in mind, this digital FAQ index offers succinct and relevant information for all practicing pulmonology and cardiology learners. What are some of the emerging therapies for PAH, and how do they differ from current treatment options? Which emerging the...
|
|
Ensuring Gender-Affirming Health Care for Transgender and Gender-Diverse Youth
Transgender youth see higher rates of suicide, poorer health outcomes, and an overall lack of access to quality care. In this expert interview, join pediatrician and child psychiatrist, Jason Rafferty, MD, MPH, EdM, from the Warren Alpert Medical School of Brown University, on a path to ensuring equitable and comprehensive healthcare for transgender and gender diverse youth. Ensure your transgen...
|
|
Eosinophilic Esophagitis (EoE) Essentials for the Multidisciplinary Provider Team
The current standard of care for patients with EoE is suboptimal and often achieves only limited relief of symptoms. However, an approved therapy is now available and novel therapeutic options continue to be evaluated as management of this disease evolves rapidly. This self-paced, interactive education includes a personalized learning assessment that is designed to sharpen your knowledge and com...
|
|
Evolving Recommendations and Strategies for Vaccine Selection in Populations at Risk for Severe Influenza-related Illness
Are you current with the recent data and guidance on influenza vaccine selection based on age, risk factors, and individual characteristics? Do you know about the most recently approved and emerging vaccines? Access this comprehensive 60-minute, CME Touchpoint that will walk you through an overview of novel and emerging influenza vaccines and their potential roles in preventative medicine. This ...
|
|
Exploring Emerging Therapeutic Opportunities for Menopausal Women with Autoimmune Disease
Expert endocrinologist Ekta Kapoor, MBBS, and leading rheumatologist, Mehret Birru Talabi, MD, PhD, discuss the menopause experience for women with autoimmune conditions including the risks associated with hormone replacement therapy (HRT) in antiphospholipid (aPL)-positive patients, recommended management of vasomotor symptoms (VMS) with concomitant autoimmune diseases, and the potential with e...
|
|
How I Treat Paroxysmal Nocturnal Hemoglobinuria (PNH)
In this point-counterpoint digital activity, two expert faculty discuss and debate treatment selection for patients with PNH through case-based scenarios. Faculty review mechanisms of action, clinical trial data, and real-world evidence supporting divergent treatment strategies for the presented cases. How do the experts make their initial treatment selections? Why might they choose a C5 inhibit...
|
|
Improving Screening and Early Diagnosis of Alpha-1 Antitrypsin Deficiency (AATD): Why Is the Unacceptable, Acceptable?
To facilitate the diagnosis and management of alpha-1 antitrypsin deficiency (AATD), clinicians require an understanding of the patient and clinical characteristics that should prompt screening, including a family history and signs of lung or liver involvement. This educational tool supports an easy translation of knowledge and encourages informed decision making for screening and testing patien...
|
|
Multidisciplinary Strategies to Prevent Hospitalization in Patients with Worsening Heart Failure
Despite guideline-directed medical therapy, many patients with heart failure (HF) with reduced ejection fraction continue to experience worsening HF and hospitalizations. As such, it is incumbent upon clinicians to improve familiarity and competence with available therapies and clinical trial data that may guide patient selection to individualize and optimize therapy for patients with HF. In thi...
|
|
New Conversations About Long-Acting Reversible Contraceptives: Patient Stories and Expert Reflections
Despite having the highest rates of effectiveness amongst contraceptives, few women in the U.S. use long-acting reversible contraceptives (LARCs), placing them at risk of unintended pregnancies. Myriad of clinician, systemic, and patient factors contribute to low rates of use. Education on the appropriate use of LARCs along with proper insertion techniques has been demonstrated to increase their...
|
|
Parenteral Nutrition Solutions: Developing a Playbook for the Multidisciplinary Team
In these symposium highlights, a multidisciplinary panel of experts discuss a range of topics, including the role of indirect calorimetry, protein requirements, intravenous lipid emulsions, and the nutrition support team. Also highlighted are a real-world patient case and the questions and answers/panel discussion. An accompanying infographic on the importance of the nutrition support team and h...
|
|
Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure
Many patients with heart failure (HF) do not receive foundational treatment although these therapies reduce morbidity and mortality risks. The initiation and optimization of guideline-directed medical therapies (GDMT) can be challenging, but clinical practice guidelines and algorithms are available to assist.
Navigate through this interactive self-directed CME activity to apply the most recen...
|
|
Pathways to Developing Personalized Treatment Regimens for Patients with Advanced Melanoma
No two patients with advanced melanoma are the same and tailoring treatment is vital. Immerse yourself in this interactive “choose your path” digital algorithm with expert perspectives to assist with the application of new guidelines and treatment options to optimize therapy.
Do you have questions about treating patients with advanced melanoma? Do you wonder…
• When to use immune ch...
|
|
Patients are Talking: Change is Needed in How We Manage Endometriosis
The average time to an endometriosis (EM) diagnosis continues to be a staggering 10 years, though this time may be even longer in women of color. Clinicians need to learn how to address these ongoing delays in EM care. Hear real patient stories and learn real-world strategies to reduce diagnostic delays, address treatment misconceptions, and navigate challenges in care that racially diverse wome...
|
|
Ready, Set, Action: Collaborative Management to Improve Diagnosis of Alzheimer Disease
It can be a struggle to diagnose Alzheimer disease (AD), but it is worth the time and effort! The benefits of a timely diagnosis for both patients and families cannot be overstated. Do you have questions about appropriate tests you can use in daily practice? Do you do cognitive, imaging, and/or biomarker tests when you suspect AD? Do you sometimes wonder how to talk about AD and diagnostic tests...
|
|
Recurring Problems, New Solutions: Interrupting the Cycle of Recurrence in Clostridioides difficile Infection
Symposium highlights from a live session at a national conference where C. diff experts, Dr. Paul Feuerstadt, Dr. Kevin Garey, and Dr. Carolyn Alonso present a variety of patient cases highlighting how to best interrupt the cycle of CDI recurrence. Faculty also discuss the risks of recurrence as well as current guidelines for CDI treatment and prevention.
View the patient cases and expanded ins...
|
|
State-of-the-Art Obesity Management in the Primary Care Setting
Access our robust online slide library covering the management of obesity in the primary care setting. Expert faculty in weight management developed content related to epidemiology, pathophysiology, and complications of obesity; screening and diagnosis; patient counseling; case studies; nonpharmacologic therapies; and pharmacologic therapies. Choose your topic interests and customize your own sl...
|
|
The Pharmacist’s Role in Managing Patients with Worsening Heart Failure
Pharmacists play a vital role in the management of patients with heart failure (HF). Navigate through this interactive self-directed, pharmacist-targeted activity designed to optimize your decision-making to apply the most recent clinical trial data and guidance seen in real-world HF practice, particularly in patients with worsening HF and after recent HF hospitalization. Expert perspectives and...
|
|
Therapeutic Advancements for the Treatment of High-Risk MDS: Future Opportunities to Improve Patient Survival and Quality of Life
Are you up to date on MDS? Engage with a leading oncology expert on recent changes in MDS classification and risk assessment of risk. Learn about emerging therapies for high-risk MDS and how they may impact clinical practice through case discussions.
Do you have questions about the latest in MDS, such as:
- What are the classifications of MDS?
- What is the IPSS-M, and how do I use it to...
|
|